Lysophosphatidic acid (LPA) protects primary chronic lymphocytic leukemia (CLL) cells from apoptosis: Role for LPA as a survival factor in CLL.

被引：0
|
作者：
Gibson, SB [1 ]
Hu, XJ [1 ]
Haney, N [1 ]
Kabore, AF [1 ]
Johnston, JB [1 ]
机构：
[1] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB, Canada
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.4788.4788
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4788
引用
收藏
页码：280B / 280B
页数：1
相关论文
共 50 条
  • [21] The transcription factor IRF-4 is related to prognosis in Chronic Lymphocytic Leukemia (CLL) and involved in proliferation and survival
    Asslaber, D.
    Hofbauer, Pinon J.
    Zaborsky, N.
    Kocher, T.
    Hartmann, T. N.
    Greil, R.
    Egle, A.
    ONKOLOGIE, 2013, 36 : 222 - 223
  • [22] Docosahexaenoic acid induces apoptosis in primary chronic lymphocytic leukemia cells
    Guieze, Romain
    Gyan, Emmanuel
    Tournilhac, Olivier
    Halty, Christelle
    Veyrat-Masson, Richard
    Akil, Saida
    Berger, Marc
    Herault, Olivier
    Callanan, Mary
    Bay, Jacques-Olivier
    HEMATOLOGY REPORTS, 2015, 7 (04) : 90 - 92
  • [23] Blood "nurse-like" cells of patients with B cell chronic lymphocytic leukemia (B-CLL) prevent in vitro apoptosis of CLL B cells.
    Burger, JA
    Kipps, TJ
    BLOOD, 1999, 94 (10) : 633A - 633A
  • [24] Mechanisms of marrow stromal cells (MSC) rescuing chronic lymphocytic leukemia (CLL) lymphocytes from forodesine-induced apoptosis
    Balakrishnan, Kumudha
    Burger, Jan
    Quiroga, Maite
    Wierda, William
    Gandhi, Varsha
    CANCER RESEARCH, 2009, 69
  • [25] Combined Inhibition of mTOR and DNA-PK Blocks Survival, Adhesion, Proliferation and Chemoresistance in Primary Chronic Lymphocytic Leukemia (CLL) Cells
    Thijssen, Rachel
    van Bochove, Gregor
    Derks, Ingrid Am
    ter Burg, Johanna
    de Rooij, Martin F. M.
    Spaargaren, Marcel
    Kersten, Marie Jose
    Eldering, Eric
    Kater, Arnon P.
    BLOOD, 2014, 124 (21)
  • [26] The HDAC inhibitor Trichostatin A induces apoptosis in chronic lymphocytic leukemia cells (CLL) in a highly effective and selective manner
    Peiffer, L.
    Poll-Wolbeck, S. J.
    Kreuzer, K-A
    Hallek, M.
    ONKOLOGIE, 2013, 36 : 173 - 173
  • [27] Dysfunction of T Cells from Chronic Lymphocytic Leukemia (CLL) Patients Is Linked to Disturbed Lipid and Fatty Acid Homeostasis
    Jacobs, Chaja Feige
    Peters, Fleur
    Cretenet, Gaspard
    Eldering, Eric
    Zelcer, Noam
    Kater, Arnon P.
    Simon-Molas, Helga
    BLOOD, 2022, 140 : 6998 - 6999
  • [28] Benzylamide sulindac analogues induce changes in cell shape, loss of microtubules and G2-M arrest in a chronic lymphocytic leukemia (CLL) cell line and apoptosis in primary CLL cells
    Moon, EY
    Lerner, A
    CANCER RESEARCH, 2002, 62 (20) : 5711 - 5719
  • [29] Receptors for vascular endothelial growth factor (VEGF) are expressed on B-chronic lymphocytic leukemia (CLL) cells
    Bairey, O
    Zimra, Y
    Rabizadeh, E
    Shaklai, M
    BLOOD, 2001, 98 (11) : 281B - 281B
  • [30] The Aggressive Molecular Signature of Peripheral Blood Chronic Lymphocytic Leukemia (CLL) Cells From Patients with Bulky Lymphadenopathy Closely Resembles That of CLL Cells From Lymph Nodes
    Mittal, Amit K.
    Iqbal, Javeed
    Gilling, Christine E.
    Moragues, Margaret
    Bociek, R. Gregory
    Aoun, Patricia
    Weisenburger, Dennis D.
    Joshi, Shantaram S.
    BLOOD, 2011, 118 (21) : 1653 - 1653
12345